H2o Therapeutics Gets FDA Clearance for Its Apple Watch-Based App for Parkinson's Disease
November 20, 2022 09:01 ET
|
h2o therapeutics
ANKARA, Turkey, Nov. 20, 2022 (GLOBE NEWSWIRE) -- Digital health start-up H2o therapeutics received 510(k) marketing clearance from the U.S. Food and Drug Administration for its prescription mobile...
Dopavision Appoints Dr. Dirk Sauer as Chair of the Company's Advisory Board
November 16, 2022 04:00 ET
|
AKAMPION
- Former Head of Novartis' Ophthalmology Development Unit to provide significant product development expertise and industry network Berlin, Germany, November 16, 2022 --- Dopavision, a...
Reach Healthcare Debuts 'Beyond the Ordinary' Immersive Technology Experience at HLTH 2022
November 03, 2022 14:31 ET
|
Reach Healthcare
SAN DIEGO, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Reach Healthcare will debut a three-part exhibition at HLTH 2022 entitled "Beyond the Ordinary." It will showcase three multi-sensory immersive solutions...
Digital Therapeutics Market Size Is Likely to Experience a Significant Growth of 21.54 by 2029, Size, Share, Trends, Growth Strategies, Financial Insights and Competitive Outlook
October 25, 2022 09:00 ET
|
Data Bridge Market Research
CHICAGO, Oct. 25, 2022 (GLOBE NEWSWIRE) -- A Qualitative Research Study accomplished by Data Bridge Market research's database, titled “Digital Therapeutics Market” with 100+ market data Tables, Pie...
BrightInsight Adds Xealth, Woebot Health and Claritas Rx to the BrightInsight Ecosystem
September 27, 2022 08:30 ET
|
BrightInsight
SAN JOSE, Calif., Sept. 27, 2022 (GLOBE NEWSWIRE) -- BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced today the...
Feel Therapeutics Launches its Ground-breaking Digital Precision Medicine Platform to Enable the Era of Precision Neuroscience and Psychiatry
September 22, 2022 07:41 ET
|
Feel Therapeutics
SAN FRANCISCO, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Feel Therapeutics Inc., a leading company developing digital biomarkers and therapeutics to bring objective measurement and data in mental health,...
Wellthy Extends Global Footprint, Appoints Veteran Commercial Leader
August 10, 2022 06:00 ET
|
WELLTHY THERAPEUTICS PRIVATE LIMITED
LOS ANGELES and MUMBAI, India and PARIS, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Wellthy Therapeutics, the leader in advancing access to digital care in all parts of the world, today announced the...
Attune Ensemble™ OTC, a First-of-Its-Kind Cancer Well-Being App, is Now Available for Free to Spanish-Speaking Patients
June 09, 2022 08:00 ET
|
Blue Note Therapeutics, Inc.
SAN FRANCISCO, June 09, 2022 (GLOBE NEWSWIRE) -- Blue Note Therapeutics today announced plans to provide Spanish-speaking patients with immediate access to a new cancer-specific wellness app, attune...
OncoHealth and Blue Note Therapeutics Partner to Provide a Digital Therapeutic for Treating Cancer-Related Anxiety and Depression Symptoms
May 31, 2022 08:00 ET
|
Blue Note Therapeutics, Inc.
SAN FRANCISCO, May 31, 2022 (GLOBE NEWSWIRE) -- Blue Note Therapeutics, a prescription digital therapeutics (PDT) company dedicated to easing the burden of cancer and improving outcomes, and...
Dopavision Appoints Mark S. Wuttke, Ph.D., as Chief Executive Officer
May 25, 2022 04:05 ET
|
AKAMPION
- Former Novartis ophthalmology program head significantly strengthens Dopavision´s management capabilities- Company recently initiated clinical trial of novel digital therapeutic for childhood myopia...